DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN – BioMarin Pharmaceutical Inc. Transaction History
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN portfolio value:
$16.42M
portfolio value
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +26.67% | 40.80K shares | 3.74M | $84.77 | 193.78K |
| Q2 2022 | share | Increase | +22.72% | 28.32K shares | 3.06M | $82.87 | 152.97K |
| Q1 2022 | share | Increase | +5.87% | 6.91K shares | -877K | $77.1 | 124.65K |
| Q4 2021 | share | Decrease | -2.46% | -2.96K shares | 1.15M | $89.08 | 117.74K |
| Q3 2021 | share | Increase | +12.40% | 13.31K shares | 369K | $77.29 | 120.71K |
| Q2 2021 | share | Increase | +65.59% | 42.53K shares | 4.06M | $83.44 | 107.39K |
| Q1 2021 | share | 0.00% | 0 shares | -750K | $75.51 | 64.85K | |
| Q4 2020 | share | Increase | +62.13% | 24.85K shares | 2.60M | $87.69 | 64.85K |
| Q3 2020 | share | 0.00% | 0 shares | -1.89M | $76.08 | 40K | |
| Q2 2020 | share | 0.00% | 0 shares | 1.55M | $123.34 | 40K | |
| Q1 2020 | share | 0.00% | 0 shares | -4K | $84.5 | 40K | |
| Q4 2019 | share | 0.00% | 0 shares | 688K | $84.55 | 40K | |
| Q3 2019 | share | 0.00% | 0 shares | -730K | $67.4 | 40K | |
| Q2 2019 | share | 0.00% | 0 shares | -127K | $85.65 | 40K | |
| Q1 2019 | share | Increase | +33.33% | 10K shares | 1.04M | $88.83 | 40K |
| Q4 2018 | share | Increase | 0.00% | 30K shares | 2.50M | $85.15 | 30K |
| Q3 2018 | share | Decrease | -100.00% | -30K shares | -2.82M | $96.97 | 0 |
| Q2 2018 | share | Decrease | -71.48% | -75.2K shares | -5.70M | $94.2 | 30K |
| Q1 2018 | share | Increase | +250.67% | 75.2K shares | 5.85M | $81.07 | 105.2K |
| Q4 2017 | share | Increase | 0.00% | 30K shares | 2.67M | $89.17 | 30K |